Selank · 10 mg

from US$80.00

Selank is a synthetic tuftsin analogue studied for GABA-related signalling, stress biology and anxiety-related outcomes.

Complimentary BAC water with every order.

Format:
Vial:

Selank is a synthetic tuftsin analogue studied for GABA-related signalling, stress biology and anxiety-related outcomes.

Complimentary BAC water with every order.

Packaging & supply options

Your format, your way.

The same research peptide, with a choice of accessories and supply formats. Here’s what each option includes.

BAC water

Vial kit

Lyophilised peptide vial with separately packaged, complimentary BAC water.

BAC water + syringes

Syringe kit

Lyophilised peptide vial, BAC water and syringes.

BAC water + pen

Injection pen kit

Lyophilised peptide vial, BAC water and an injection pen.

Pen + pen needles

Reconstituted pen

VIETNAM ONLY

Peptide solution supplied in a pen at the stated concentration, with pen needles.

For laboratory research only. Not for human or veterinary use.

Everform Pharma · Neuropeptide research

Selank.
Exploring stress and neural signalling.

A closer look at GABA-related research, anxiety studies and brain connectivity — with laboratory findings and human outcomes kept in context.

A delicate gold balancing mobile with ivory stones beside an emerald glass arch and an ivory notebook in warm sunlight, representing research into neural regulation.
A conceptual illustration of regulation and balance, not a depiction of anxiety relief or a clinical outcome.

What is Selank?

Selank is a synthetic seven-amino-acid peptide with the sequence Thr–Lys–Pro–Arg–Pro–Gly–Pro. Its design combines the tuftsin sequence with a Pro–Gly–Pro extension. It has been investigated in neuropharmacology, particularly in relation to GABA-associated signalling and anxiety-related outcomes. [2] [3]

The term “anxiolytic” describes an effect being investigated; it is not a guarantee that a research product relieves anxiety. Selank’s literature includes animal experiments, cultured-cell work and small human studies, each with different limits.

Selank and Semax are different peptides. Their names, sequences and research findings should not be treated as interchangeable.

How it works

One line of research examines the GABAergic system, which is involved in inhibitory neurotransmission. Volkova and colleagues measured changes in neurotransmission-related gene expression in rat frontal cortex after Selank or GABA exposure. Similarities at some time points suggested a connection worth investigating, rather than proving a complete human mechanism. [1]

Laboratory results also depend on the model. In human-derived IMR-32 neuroblastoma cells, Filatova and colleagues found no change in the measured gene panel with Selank alone, while combined exposures altered responses to other compounds. A human-derived cell line is not a clinical trial. [2]

These findings do not establish that Selank works identically to a benzodiazepine or can replace one. Molecular responses, perceived calm and a diagnosed anxiety disorder are distinct research endpoints.

GABA-RELATED SIGNALLING

Examining neurotransmission-associated gene expression and responses in defined experimental models.

FROM MODEL TO OUTCOME

Distinguishing cell assays, rat brain measurements, human imaging and clinical symptom scales.

Main research areas

Research areaEvidence and limits
GABA-related gene expressionRat frontal-cortex experiments examined a panel of neurotransmission genes. The findings are preclinical and depend on timing and model. [1]
Cellular signallingIMR-32 cell experiments compared Selank alone with combined exposures. Results did not show a uniform gene-expression effect from Selank alone. [2]
Anxiety-related clinical outcomesA small human study compared Selank with medazepam in patients with generalised anxiety disorder and neurasthenia. It does not establish benefits in everyone experiencing stress. [3]
Human brain connectivityA study including Selank, Semax and placebo assessed resting-state fMRI. Imaging differences are not, by themselves, evidence of better mood or cognition. [4]

Evidence from one model, population or formulation cannot automatically validate another. These studies did not test the Everform research vial.

What published findings show

Rat gene-expression study: Volkova and colleagues examined 84 neurotransmission-related genes in frontal cortex. Selank and GABA produced partly related expression patterns, with the relationship changing over time. This supports further mechanistic work, not a claim that Selank simply increases GABA throughout the brain. [1]

Human-derived cell study: Filatova and colleagues observed no change in their measured gene panel with Selank alone in IMR-32 cells. Responses differed when Selank was combined with GABA or olanzapine. These laboratory combinations are experimental conditions, not product-use recommendations. [2]

Small human comparative study: Zozulia and colleagues studied 62 patients with generalised anxiety disorder and neurasthenia: 30 received Selank and 32 received medazepam. The authors reported similar anxiety-related effects using symptom scales. The indexed abstract does not provide enough methodological detail to establish blinding or formal equivalence, and there was no placebo comparison described. [3]

Human imaging study: Panikratova and colleagues examined 52 healthy participants across Selank, Semax and placebo conditions. The study reported connectivity differences involving the right amygdala and temporal regions. A brain-network finding does not establish a clinically meaningful improvement in anxiety, focus or daily functioning. [4]

The evidence supports continued research, but does not establish guaranteed anxiety relief, improved sleep, absence of sedation, freedom from dependency or long-term safety. The cited studies do not validate the identity, quality or clinical performance of the Everform product.

The Everform product, at a glance

ProductSelank

Labelled vial amount10 mg

Vial formatLyophilised peptide powder

Supply optionsCheck the current product selector

Everform Pharma is based in Da Nang, Vietnam. The labelled 10 mg describes vial content, not a recommended dose. Complimentary BAC water is included with every order.

Explore Your format, your way →

The full REF on the product should match the relevant documentation. The security sticker repeats the product identifier and should match the vial or pen; it is not a separate new ID. Follow the actual product label for storage and expiry.

Identity, chromatographic purity and measured peptide content are different analytical results. A purity percentage alone does not establish sequence identity or the amount of peptide in a vial. Check that the documentation describes Selank and the supplied chemical form.

Explore our label and COA guide →

Common questions

Is Selank the same as Semax?

No. They are different peptides with different sequences. The human imaging paper studied them as separate conditions, not as an interchangeable product or a validated combination. [4]

Does Selank simply increase GABA?

The cited work measured gene-expression patterns and experimental responses. It does not establish a simple, universal increase in brain GABA or a complete mechanism in people. [1] [2]

Does the medazepam comparison prove equivalence?

No. Reporting similar effects in a small comparison does not establish formal equivalence or non-inferiority. Design, statistical criteria and replication matter. [3]

Is Selank proven to be non-sedating and dependency-free?

The studies discussed here do not establish those blanket assurances. Limited reporting of an adverse effect is not proof that the risk is absent.

Does a pen photograph establish a validated formulation?

No. Packaging does not establish stability, compatibility, sterility, absorption or clinical performance. These require formulation-specific evidence and documentation.

Does 10 mg describe a recommended dose?

No. It is the labelled amount in the vial, not a dose, concentration, schedule or administration instruction.

References

[1] Volkova et al. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Frontiers in Pharmacology, 2016. Rat study.

[2] Filatova et al. GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells. Frontiers in Pharmacology, 2017. Cell study.

[3] Zozulia et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, 2008. Human comparative study; Russian-language article with indexed English abstract.

[4] Panikratova et al. Functional Connectomic Approach to Studying Selank and Semax Effects. Doklady Biological Sciences, 2020. Human imaging study.

Everform Pharma · Da Nang, Vietnam
Educational product information.
For laboratory research only.
Not for human or veterinary use.